To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparative Benefits and Harms of Individual Opioids for Chronic Non-cancer Pain

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
July 2022

Comparative Benefits and Harms of Individual Opioids for Chronic Non-cancer Pain

Vol: 270| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials

Br J Anaesth. 2022 Jul 8;S0007-0912(22)00288-4.

Contributing Authors:
J Busse Noori Atefeh Sadeghirad Behnam Wang Li Siemieniuk Reed A C Shokoohi Mostafa Kum Elena Jeddi Mark Montoya Luis Hong Patrick J Zhou Edward Couban Rachel J Juurlink David N Thabane Lehana Bhandari Mohit Guyatt Gordon H Busse Jason W

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

82 randomized controlled trials including 22,619 patients with chronic non-cancer pain were included in this network meta-analysis investigating the relative benefits and harms of individual opioids in both extended-release (ER) and immediate-release (IR) formulations. Outcomes of interest included pain relief, function, and gastrointestinal adverse events (vomiting; constipation; nausea). Results...

Join the Conversation

Please Login or Join to leave comments.